Enterprise AI Spend in Pharma Trial Recruitment 2026

Frequently Asked Questions

01.What is AI trial recruitment in pharma?

AI trial recruitment is software that matches patients to clinical trial eligibility criteria using retrieval and language models over protocol documents and electronic health records, replacing manual chart review by coordinators with an automated screening pass that surfaces candidates faster.

02.How does trial recruitment AI spend differ from broader pharma AI spend?

Broader pharma AI spend covers drug discovery, manufacturing, and biomarker modeling. Trial recruitment AI spend is a narrower, outcome-tied slice funding eligibility-matching systems, coordinator-facing retrieval tools, and enrollment-forecasting models that are underwritten against screening speed and enrollment rate, not discovery timelines.

03.Who should evaluate AI spend in pharma trial recruitment before allocating capital?

Capital allocators funding clinical-technology vendors, PE and growth-equity teams underwriting site-network and CRO roll-ups, and sponsors comparing recruitment platforms should evaluate this spend, since pharmaceutical and biotech sponsors already hold the largest share of the recruitment AI market.